Gestational diabetes mellitus: results from a survey of country prevalence and practices

Jiwani, Aliya; Marseille, Elliot; Lohse, Nicolai; Damm, Peter; Hod, Moshe; Kahn, James G.

doi:10.3109/14767058.2011.587921

Cited by 255 publications

(160 citation statements)

References 54 publications

Supporting

Mentioning

151

Contrasting

Unclassified

Order By: Relevance

“…Recent surveys demonstrate the strong variability internationally in screening, diagnosis and treatment of women with GDM [22]. A recent review also shows that screening and management of GDM is very variable across Europe, partly due to the ongoing controversy and inadequate clinician awareness of GDM [23].…”

Section: An Ebcog Initiative To Develop a Proposal For The Use Of Unimentioning

confidence: 99%

A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG)

et al. 2015

Self Cite

View full text Add to dashboard Cite

Screening and diagnostic criteria for gestational diabetes (GDM) are inconsistent across Europe, and the development of a uniform GDM screening strategy is necessary. Such a strategy would create opportunities for more women to receive timely treatment for GDM. Developing a consensus on screening for GDM in Europe is challenging, as populations are diverse and healthcare delivery systems also differ. The European Board & College of Obstetrics and Gynaecology (EBCOG) has responded to this challenge by appointing a steering committee, including members of the EBCOG and the Diabetic Pregnancy Study Group (DPSG) associated with the EASD, to develop a proposal for the use of uniform diagnostic criteria for GDM in Europe. A proposal has been developed and has now been approved by the Council of the EBCOG. The current proposal is to screen for overt diabetes at the first prenatal contact using cut-off values for diabetes outside pregnancy, with particular efforts made to screen high-risk groups. When screening for GDM is performed at 24 weeks' gestation or later, the proposal is now to use the 75 g OGTT with the new WHO diagnostic criteria for GDM. However, more research is necessary to evaluate the best GDM screening strategy for different populations in Europe. Therefore, no clear recommendation has been made on whether a universal one-step, two-step or a risk-factorbased screening approach should be used. The use of the same WHO diagnostic GDM criteria across Europe will be an important step towards uniformity.

show abstract

Section: An Ebcog Initiative To Develop a Proposal For The Use Of Unimentioning

confidence: 99%

A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG)

et al. 2015

Self Cite

View full text Add to dashboard Cite

show abstract

“…The world-wide prevalence of gestational diabetes is poorly documented, but reportedly varies from 0.1 -25.3% 27 . Maternal obesity, now occurring in 15 -20% of pregnancies, is a strong risk factor for gestational diabetes, as is maternal prematurity 25,28 .…”

Section: Developmental Determinants Of Low Nephron Numbermentioning

confidence: 99%

Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease

et al. 2013

View full text Add to dashboard Cite

Developmental programming of non-communicable diseases is now an established paradigm. With respect to hypertension and chronic kidney disease, adverse events experienced in utero can affect development of the fetal kidney and reduce final nephron number. Low birth weight and prematurity are the most consistent clinical surrogates for a low nephron number, and are associated with increased risk of hypertension, proteinuria and kidney disease in later life. Rapid weight gain in childhood or adolescence further compounds these risks. Low birth weight, prematurity and rapid childhood weight gain should alert clinicians to an individual's life-long risk of hypertension and kidney disease, prompting education to minimize additional risk factors and ensuring follow-up. Birth weight and prematurity are significantly impacted by maternal nutrition and health during pregnancy. Optimization of maternal health and early childhood nutrition could therefore attenuate this programming cycle and reduce the global burden of hypertension and kidney disease in the future.

show abstract

“…Even some high-income countries employ selective screening [12]. Overreliance on adequate nutrition and a fear of administering insulin by health care workers based on fear of hypoglycaemia are oth-er reasons for poorly controlled diabetes during pregnancy [13].…”

Section: Introductionmentioning

confidence: 99%

Barriers and Facilitators of Adherence to Anti-Diabetic Therapy in Pregnant Women with Diabetes: Health Care Workers’ Perspectives

Mukona¹,

Munjanja²,

Zvinavashe³

et al. 2017

JDM

View full text Add to dashboard Cite

Global prevalence of hyperglycaemia in pregnancy in women of 20 -49 years was estimated to be 16.9% and affecting 21.4 million live births, in 2013, 90% of which occurred in developing countries. The cornerstone of anti-diabetic therapy is diet, physical activity and medications. The study utilized a qualitative descriptive design using key informant interviews from August 2016 to November 2016 to explore challenges of adherence to anti-diabetic therapy in pregnant women with diabetes at a central hospital in Harare, Zimbabwe. Permission to conduct the study was obtained from the respective local and national ethical review boards. All participants gave verbal and written informed consent. A sample of eight key informants directly involved in the care of pregnant women with diabetes was purposively selected for key informant interviews. Key informants should have worked with diabetic pregnant women for at least one year. Sample size was determined by data saturation. Interviews followed a semi structured questionnaire that had sections on the burden of diabetes in pregnancy, challenges of adherence, challenges in management and possible solutions to challenges faced. All interviews were conducted in a private room. Detailed notes were taken during the interviews which were also being audiotaped. Trustworthiness was achieved by observing credibility, dependability, transferability and confirmability. Thematic analysis was done. Thematic analysis was done manually. The stages of data analysis followed were data organization, familiarization, transcription, coding, developing a thematic framework, indexing, displaying and reporting. Major themes identified were barriers and facilitators of adherence to anti-diabetic therapy. Categories under barriers were financial barriers, lack of health edu- 161cation, lack of trained personnel, shortage of staff and lack of collaboration among practitioners. Categories under facilitators of adherence were subsidization of care, formal training of professionals, promoting collaboration and establishment of a unit dedicated to the care of pregnant women with diabetes. Barriers and solutions identified should be utilized to develop frameworks to promote adherence to anti-diabetic therapy incidence of adverse perinatal outcomes.

show abstract

Gestational diabetes mellitus: results from a survey of country prevalence and practices

Cited by 255 publications

References 54 publications

A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG)

A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG)

Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease

Barriers and Facilitators of Adherence to Anti-Diabetic Therapy in Pregnant Women with Diabetes: Health Care Workers’ Perspectives

Contact Info

Product

Resources

About